Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. Queensland was the source of 51% of prescriptions between 2016 and 2021. We are aware of clinical trials in that space, but not strong evidence.”. The Guardian writes.

Medicine 52

Medicine Clinical Trials Data Sleep 52

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats). Hepatic protection.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions.

Recreational 73

Recreational Hemp THC Legalization 73

Cannabis Law Report

MAY 10, 2022

Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Very few studies have also been done examining cannabis for the treatment of sleep disorders.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Greencamp

FEBRUARY 2, 2019

Drugs used for the treatment of HIV and AIDS are called antiretroviral medications, and there are several different classes of these drugs: Fusion/Entry Inhibitors (they prevent, or more precisely slow down HIV from entering healthy cells). 2016 ( 3 ). How classical pharmaceuticals fight HIV. Thames, Zanjbeel Mahmood, Alison C.

Marijuana 110

Marijuana Therapy Cannabinoids Patients 110

Cannabis Law Report

DECEMBER 14, 2019

Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. Clinical stage CBD company Botanix Pharmaceuticals (ASX: BDA ) works on using cannabidiol (CBD) in its treatment of skin conditions including acne, psoriasis, dermatitis and rosacea.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

The Cannigma

SEPTEMBER 21, 2021

“I’ve actually tried (marijuana) twice during the last year and a half when I’ve been going through this pain, this chronic pain that I’ve been dealing with,” Kerr said in a 2016 interview. But Tommy Chong’s use of cannabis as a personal medical treatment is far less widely known. 7) Morgan Freeman.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

SEPTEMBER 1, 2019

By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. In late 2016, Faenza was working with a team to identify potential Australian sites and scan the international market for the best production methods.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

The Cannigma

AUGUST 26, 2021

The country legalized medical cannabis in 2016, but patients in the country have long criticized the program as too restrictive, and access to cannabis-based medicines remains behind that of many other legal cannabis jurisdictions. percent) remains far higher than the world average (3.9 Costs of medical marijuana.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Growing adoption of medical marijuana for treatment of chronic diseases. Market Segmentation. Market Dynamics. Supplements.

Legalization 40

Legalization Supply Chain Chronic Pain Recreational 40

Cannabis Law Report

NOVEMBER 17, 2021

Creso Pharma was set up to develop, register and commercialise pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments in 2015, and listed on the ASX in 2016. It is the sort of stock that bounces around at the smaller end of the market, at the whim of day-traders and at times online investing forums.

Clinical Trials 52

Clinical Trials Pharmaceutical Hemp Medicine 52

SpeedWeed

AUGUST 4, 2021

I attended my first medical cannabis symposium in Sydney in 2016. This event saw doctors and researchers from all over the world presenting the scientific and clinical studies surrounding the medical benefits of cannabis. . They presented case studies about patients who have had incredible success from their cannabis treatments.

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Cannabis Law Report

MARCH 21, 2019

In order to legally posses CBD in Alabama , you must be in accordance to Leni’s Law which states you must be diagnosed with a debilitating medical condition and be undergoing treatment or you are part of a state-sponsored clinical trial. In 2016, Tennessee legalized the use of CBD containing no more than 0.9%

State Laws 55

State Laws Law CBD Legalization 55

Cannabis Law Report

OCTOBER 3, 2019

Professor John McMillan AO’s review was conducted on the extensive amendments made to the ND Act in 2016, which established a regime for the cultivation, production and manufacture of medicinal cannabis in Australia. The number of applications received was three times higher than that which was forecasted in 2016.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

Cannabis Law Report

JUNE 30, 2019

The House also included amendments transferring $5 million from the Drug Enforcement Administration to opioid treatment programs, and directing the Food and Drug Administration to establish regulations for adding CBD to food and dietary supplements. The panel also took up a bill sponsored by Rep. Medical / Health.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Legalisation occurred in Australia in 2016. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). 2016 ; Sznitman et al. Background. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 11, 2019

First, the court distinguished between treatments which “serve the sole function of making the plaintiff’s life more bearable or enjoyable” and those that are “reasonably necessary to preserve the plaintiff’s health” 31 Only the latter are compensable. In rejecting the claim, the court cited Torchia v.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

SEPTEMBER 3, 2019

Federal legislation to enable the production and sale of cannabis for medical use and related research purposes was passed by Australia’s parliament in 2016. The laws allow concentrate-based medical cannabis to be prescribed in Australia for the treatment of a variety of specific illnesses. Australian Leadership Appointments.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

JANUARY 20, 2022

Eleusis designed ELE-Psilo, a proprietary psilocybin-based drug candidate that is formulated for IV infusion and in development for the treatment of depression. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K. About Silver Spike Capital.

Therapy 40

Therapy Research and Development Business Access 40

Cannabis Law Report

DECEMBER 21, 2021

According to Fundera, these industries anticipate 115 – 121% job growth over ten years (2016-2026). Ignite products are ecologically responsible and do not require additional wastewater treatment. With instant screening test results, both patient and physician receive precious time to develop treatment plans.

Research and Development 40

Research and Development Supply Chain Data Business 40

Project CBD

OCTOBER 26, 2023

They conducted a double-blind, placebo-controlled phase 2 clinical trial using Sativex® in conjunction with temozolomide to treat recurrent glioblastoma multiforme (GBM). As part of the approval process for all markets, they have conducted critical Phase 2 studies on various conditions, including cancer. mg of THC and 30 mg of CBD.

Research and Development 347

Research and Development Cannabinoids Terpenes Pharmaceutical 347

FloridaMarijuana.net

AUGUST 13, 2018

There are a variety of treatment options to help patients cope with and heal from anxiety disorders. Cannabis has potential for the treatment of PTSD and substance use disorders. The Journal of Affective Disorders published a 2016 Swedish study which surveyed 8598 Swedish men and women. Finnell and Laurie K.

Marijuana 145

Marijuana Patients Clinical Trials Conditions 145

The Cannigma

OCTOBER 19, 2021

A clinical trial published in 2015 found that the test subjects had “significantly higher blood THC” levels when they used cannabis along with alcohol, and combining the two led to increased performance impairment. The researchers added that people in treatment for AUD might benefit from stopping or reducing their cannabis use.

Research and Development 128

Research and Development Clinical Trials Edibles THC 128

CannaMD

MARCH 8, 2021

Prohibiting a medical marijuana treatment center from dispensing marijuana that exceeds a certain potency of tetrahydrocannabinol [p. Revising a provision relating to the potency of tetrahydrocannabinol in edibles dispensed by a medical marijuana treatment center [p.1, 2, line 32]. 2, line 38]. 1, line 12]. 2, line 26]. 2, line 29].

THC 116

THC Research and Development Treatment Patients 116

Canna Law Blog

MAY 7, 2020

for various studies, including FDA-approved clinical trials. In 2016, the DEA finally shifted to different treatment around expanded research efforts into cannabis beyond Ole Miss. These cannabis products are used by researchers in the U.S.

DEA 96

DEA Research and Development Cultivation Supply Chain 96

The Cannigma

MAY 13, 2022

Over 10% of US adults have suffered from some degree of daily pain for at least three months, so the need for improved treatment is clear. There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. 12 Pinene had the ability to meditate chemical responses to inflammation in rodent trials.

Terpenes 111

Terpenes Strains Chronic Pain Clinical Trials 111

CannaMD

NOVEMBER 6, 2019

In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 Medical cannabis is an effective and safe alternative for pain treatment. million to 11.4 More Information.

Marijuana 107

Marijuana Patients Clinical Trials Data 107

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

The Cannigma

JANUARY 13, 2023

The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” Daily cannabis consumption was an effective treatment for 85% of participants. This system shows up in several studies. headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] Clinical Trials and Human Subject Protections. Trial of Psilocybin Versus Escitalopram for Depression , 384 New England J.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. They’re an effective treatment for pain, but they’re not great for chronic pain, and many people are reluctant to start on opioids,” he said.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 7/2016 (498-501). 1Alexandra L.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Green Relief

MAY 13, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. An estimated 4 million to 6 million Americans are on disability because of TBI.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Treatment modalities for TBI are limited with few satisfactory pharmaceutical options available. An estimated 4 million to 6 million Americans are on disability because of TBI.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40